Oncology - Medicine.net

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou

Updated on: January 26,2024

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou

Updated on:January 26,2024

Novel radiotracer identifies critical cancer biomarker, opens door to new therapeutic target for solid tumors

by Society of Nuclear Medicine and Molecular Imaging[18F]AlF-RESCA-T4 immuno-PET/CT imaging of patient with primary lung cancer. (A–C) Maximum-intensity projection (A) and fusion images (B and C) of [

Updated on: January 09,2025

Novel radiotracer identifies critical cancer biomarker, opens door to new therapeutic target for solid tumors

by Society of Nuclear Medicine and Molecular Imaging[18F]AlF-RESCA-T4 immuno-PET/CT imaging of patient with primary lung cancer. (A–C) Maximum-intensity projection (A) and fusion images (B and C) of [

Updated on:January 09,2025

Scientists identify promising therapeutic target for incurable brain cancer

byVirginia Commonwealth UniversityCredit: Unsplash/CC0 Public DomainResearchers at VCU Massey Cancer Center discovered a cellular partnership that drives the growth of deadly brain tumors and co

Updated on: December 27,2023

Scientists identify promising therapeutic target for incurable brain cancer

byVirginia Commonwealth UniversityCredit: Unsplash/CC0 Public DomainResearchers at VCU Massey Cancer Center discovered a cellular partnership that drives the growth of deadly brain tumors and co

Updated on:December 27,2023

Step-by-Step "Blood Replacement": A New ADC Therapy for Precise Tumor Elimination

Updated on: May 29,2024

Step-by-Step "Blood Replacement": A New ADC Therapy for Precise Tumor Elimination

Updated on:May 29,2024

Analysis of Medicine:Metabolic reprogramming in the tumor microenvironment modulates tumor immune response and immunotherapy

Updated on: April 17,2024

Analysis of Medicine:Metabolic reprogramming in the tumor microenvironment modulates tumor immune response and immunotherapy

Updated on:April 17,2024

How gut bacteria can impact treatments for cancer

by Bob Yirka , Medical XpressTreatment with 3-IAA and FIRINOX results in reduced autophagic activity. a, Gnotobiotic mice were colonized with R microbiota and KPC cells were orthotopically injected. M

Updated on: December 19,2023

How gut bacteria can impact treatments for cancer

by Bob Yirka , Medical XpressTreatment with 3-IAA and FIRINOX results in reduced autophagic activity. a, Gnotobiotic mice were colonized with R microbiota and KPC cells were orthotopically injected. M

Updated on:December 19,2023

From vaccines to AI: New weapons in the fight against cancer

Credit: CC0 Public DomainCould humanity finally be gaining the upper hand in our age-old fight against cancer?Recent scientific and medical advances have added several new weapons to our arsenal, incl

Updated on: December 19,2023

From vaccines to AI: New weapons in the fight against cancer

Credit: CC0 Public DomainCould humanity finally be gaining the upper hand in our age-old fight against cancer?Recent scientific and medical advances have added several new weapons to our arsenal, incl

Updated on:December 19,2023

$Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma$

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye

Updated on: October 24,2023

$Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma$

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

Novel radiotracer identifies critical cancer biomarker, opens door to new therapeutic target for solid tumors

Novel radiotracer identifies critical cancer biomarker, opens door to new therapeutic target for solid tumors

Scientists identify promising therapeutic target for incurable brain cancer

Scientists identify promising therapeutic target for incurable brain cancer

Step-by-Step "Blood Replacement": A New ADC Therapy for Precise Tumor Elimination

Step-by-Step "Blood Replacement": A New ADC Therapy for Precise Tumor Elimination

Analysis of Medicine:Metabolic reprogramming in the tumor microenvironment modulates tumor immune response and immunotherapy

Analysis of Medicine:Metabolic reprogramming in the tumor microenvironment modulates tumor immune response and immunotherapy

How gut bacteria can impact treatments for cancer

How gut bacteria can impact treatments for cancer

From vaccines to AI: New weapons in the fight against cancer

From vaccines to AI: New weapons in the fight against cancer

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

Deep learning can predict lung cancer risk from single LDCT scan

Deep learning can predict lung cancer risk from single LDCT scan

Novel photoacoustic contrast agent offers safer, cost-effective imaging for tumors

Novel photoacoustic contrast agent offers safer, cost-effective imaging for tumors

HER2+ early breast cancers where shorter-course trastuzumab could be an option

HER2+ early breast cancers where shorter-course trastuzumab could be an option